AKT1 and metabolic dysfunction-associated steatotic liver disease: In particular, we explored the effects of PF on improving fatty liver and IR in NAFLD rats based on its effects on the lipid metabolism-associated regulators and insulin-associated IRS/Akt/GSK3β pathway.